Senate Investigating High Price of Asthma Inhalers
The U.S. Senate’s Health, Education, Labor, and Pensions (HELP) Committee announced this week that they are conducting an investigation into the high cost of asthma inhalers.
AAFA is hopeful this investigation will lead to a national conversation about asthma drug costs and produce action that breaks down barriers to affordable treatment for people with asthma.
Last fall, AAFA shared the patient perspective with the HELP Committee, and research from AAFA helped inform the committee’s investigation framework.
Read more about AAFA’s work to help address cost barriers that prevent effective treatment of asthma.
|